15-valent recombinant human papillomavirus vaccine (Shanghai Bovax Bio)

N/A

Report date: 2025/06/11 10:26:41

Base Information

Drug Name15-valent recombinant human papillomavirus vaccine (Shanghai Bovax Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVulvar Intraepithelial NeoplasiaPenile NeoplasmsVaginal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Bovax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Bovax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsVulvar Intraepithelial NeoplasiaPenile NeoplasmsVaginal Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A